Wall Street PR

Donna Fago

A -59% Return Since Transcept’s FDA Approval

When Transcept Pharmaceuticals (NASDAQ: TSPT) received FDA approval for its four-hour sleeping pill, Intermezzo, its stock was trading as high as $12.99 per share. Today,

A -59% Return Since Transcept’s FDA Approval

When Transcept Pharmaceuticals (NASDAQ: TSPT) received FDA approval for its four-hour sleeping pill, Intermezzo, its stock was trading as high as $12.99 per share. Today,